Download Complete Investment Portfolio 
Investments
Allos Therapeutics, Inc.
Biopharmaceutical company focused on developing and commercializing innovative drugs for improving cancer treatments.
AVECOR Cardiovascular, Inc.
(Acq. by Medtronic)
Provider of lifelong solutions for people with chronic disease. Develops and manufactures products that treat a variety of disorders of the cranium and spine, including traumatically induced conditions, degenerative conditions, deformities and tumors.
Cardiac Pathways Corporation
(Acq. by Boston Scientific)
Designs, develops, and manufactures minimally invasive systems to diagnose and treat cardiac tachyarrhythmias (abnormally rapid heart rhythms) which, if untreated, can cause palpitations, fainting, and sudden cardiac arrest.
Cephalon, Inc.
An international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat sleep and neurological disorders, cancer and pain.
Esperion Therapeutics, Inc.
A biopharmaceutical company dedicated to the discovery, development and commercialization of a novel class of therapies to treat cardiovascular and metabolic diseases, including atherosclerosis, as they relate to high density lipoprotein cholesterol, “HDL-C”, also known as the “good” cholesterol.
Genzyme Corporation
Biotechnology company that develops and markets innovative products and services designed to address significant unmet medical needs.
OraPharma, Inc.
(Acq. by Johnson & Johnson)
A specialty pharmaceutical company that discovers, develops and commercializes therapeutics for oral health.
Tengion, Inc.
Tengion is a leader in the field of regenerative medicine. The Company is developing new human tissues and organs (neo-tissues and neo-organs) that are derived from a patient's own cells. Tengion's patented technology harnesses the body's ability to regenerate, and it has the potential to allow adults and children with organ failure to have functioning organs built from their (autologous) tissues.
ViroPharma, Inc.
Developer of antiviral therapies that attack the underlying causes of viral diseases. The company's product candidates are at various stages of development.